Sign in
8-K/A

Current Report

NRX Pharmaceuticals, Inc. Filed Acc 0001437749-25-036005

Exhibits

  • Item 9.01 Financial statements and exhibits

From the SEC's structured data for this filing

Loading nrxp20251118_8ka.htm…